Table 2 Characteristics of the retracted non-Cochrane SRS
No | Journal name | No. of articles (%) |
|---|---|---|
1 | Tumor Biology | 26 (9.2) |
2 | Computational and Mathematical Methods in Medicine | 24 (8.5) |
3 | Biomed Research International | 14 (4.96) |
4 | Molecular Biology Reports | 14 (4.96) |
5 | Medicine | 12(4.25) |
6 | PloS One | 10(3.54) |
7 | Journal of Healthcare Engineering | 8 (2.82) |
8 | Contrast Media & Molecular Imaging | 6 (2.12) |
9 | Frontiers in Surgery | 6 (2.12) |
10 | European Journal of Medical Research | 5(1.77) |
11 | Evidence-Based Complementary and Alternative Medicine | 5(1.77) |
12 | Computational Intelligence and Neuroscience | 4 (1.41) |
13 | Journal of Orthopedic Surgery and Research | 4(1.41) |
14 | Disease Markers | 3 (1.06) |
15 | Molecular Neurobiology | 3 (1.06) |
16 | Others | 138 (48.93) |
Impact factor of journals | No (%) | |
1 | 0 < IF ≤ 2 | 44 (15.60) |
2 | 2 < IF ≤ 4 | 193 (68.43) |
3 | 4 < IF ≤ 6 | 25 (8.86) |
4 | IF > 6 | 17 (6.02) |
5 | Not indexed in SCI | 3 (1.06) |
Country of corresponding author | No (%) | |
1 | China | 208 (73.75) |
2 | UK | 10 (3.54) |
3 | USA | 9 (3.19) |
4 | Japan | 8 (2.82) |
5 | Iran | 6 (2.12) |
6 | Australia | 5 (1.77) |
7 | Others | 36 (12.76) |